Eucommia ulmoides (Geniposidic acid)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Eucommia ulmoides (Geniposidic acid).

Eucommia ulmoides extract, standardized for geniposidic acid, functions as a potent osteoprotective and antihypertensive agent by modulating TGF-β1 signaling and promoting collagen synthesis within the extracellular matrix.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

443354

Molecular Weight

374.34 g/mol

XLogP3 (Lipophilicity)

-2.7

IUPAC Name

(1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Glucosamine Sulfate for synergistic chondroprotection and joint matrix integrity
Hawthorn Extract for enhanced blood pressure regulation via ACE inhibition pathways

Biological Formulation Enhancers

Piperine for increasing intestinal permeability and inhibiting glucuronidation of iridoid glycosides
Quercetin for improving the metabolic stability and bioavailability of geniposidic acid

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Eucommia ulmoides (Geniposidic acid) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Eucommia extracts requires moisture-resistant HPMC capsules to prevent clumping and degradation of the iridoid glycosides.

🍬 Gummy & Pectin Formats

High concentrations of geniposidic acid can impart a significant bitter profile and astringency, necessitating advanced flavor masking and pH adjustment to maintain pectin gel stability.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for Eucommia extract often exceeds the 20-30mg payload capacity of standard thin-film polymer matrices, limiting its use in this format.

For Brand Founders

Formulate with Eucommia ulmoides (Geniposidic acid)

Ready to launch a product featuring Eucommia ulmoides (Geniposidic acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Eucommia ulmoides (Geniposidic acid) Bioavailability

Need absolute proof that your Eucommia ulmoides (Geniposidic acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Eucommia ulmoides (Geniposidic acid) Degradation Testing

Is your Eucommia ulmoides (Geniposidic acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation